Home » Topics » Regulatory » Patents

Patents
RSS

Sage Therapeutics patents novel NMDA receptor modulators

Jan. 25, 2017

Rodin Therapeutics discovers new HDAC2 inhibitors

Jan. 25, 2017

Crinetics Pharmaceuticals discloses novel somatostatin sst2 receptor agonists

Jan. 24, 2017

Roche, Genentech identify novel RIP-1 inhibitors

Jan. 24, 2017

Bayer Pharma describes coagulation factor XIa and kallikrein B inhibitors

Jan. 24, 2017

Shionogi describes new high affinity nerve growth factor receptor inhibtors

Jan. 24, 2017

ViiV Healthcare UK presents novel HIV integrase inhibitors

Jan. 24, 2017

Genentech and Roche present novel PI3Kalpha and PI3Kdelta inhibitors

Jan. 23, 2017

Janssen discloses new sulfamoylarylamide derivatives for HBV infection

Jan. 23, 2017

The University of Michigan discovers GRK2, GRK5 inhibitors

Jan. 23, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...